Literature DB >> 26866095

FLUCONAZOLE AND BORIC ACID FOR TREATMENT OF VAGINAL CANDIDIASIS--NEW WORDS ABOUT OLD ISSUE.

K M Khameneie1, N Arianpour, R Roozegar, M Aklamli, M M Amiri.   

Abstract

OBJECTIVE: To compare boric acid as an effective treatment for VVC compared to fluconazole. We also studied the efficiency of these drugs in preventing recurrence of VVC.
DESIGN: A cross sectional, randomized, double-blind study. SETTINGS: Gynaecology clinic of Imam Reza hospital, Tehran - Iran
SUBJECTS: Women with signs and symptoms related to Vulvo Vaginal Candidiasis.
RESULTS: Seventy five patients out of total 150 patients with signs and symptoms related to Vulvo Vaginal Candidiasis were treatedwith boric acidpowder everynight for a week and the remaining 75 patients received Fluconazole. The cure rate in first group was 46.7% but the cure rate in second group was 37.3%. The difference was not statistically significant (P>0.3). Difference between the efficacy of the two drugs was not significant either (P=0.47). The recurrence rate among patients in first group was 35% while it was 32% in second group. Their difference was not statistically significant (P=0.54).
CONCLUSION: According to our findings, treatment of vaginal candidiasis with boric acid is as effective as fluconazole. The availability of boric acid and its relatively low cost suggests it as a safe and effective drug for treatment of candidiasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 26866095

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  3 in total

1.  Boric Acid Solution Inhibits Candida albicans Infections in Mouse Skin via the IL-23/Th17 Axis.

Authors:  Zhao Liu; Qing Liu; Yanyan Xu; Zhao Han; Ling Zhang; Xiaojing Li
Journal:  Front Microbiol       Date:  2022-06-16       Impact factor: 6.064

2.  Effects of Boric Acid Gel on Vaginal Candida albicans Infections and the Local Immune System in Mice.

Authors:  Xiaoyu Guo; Tingting Jing; Xiaojing Li; Zhao Liu; Yongxue Chen; Yiquan Li; Yanyan Xu; Hongqi Gao
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

3.  Compliance with the Updated BASHH Recurrent Vulvovaginal Candidiasis Guidelines Improves Patient Outcomes.

Authors:  Lottie Brown; Mathilde Chamula; Sharon Weinberg; Frakinda Jbueen; Riina Rautemaa-Richardson
Journal:  J Fungi (Basel)       Date:  2022-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.